Dindolyl Methane, or DIM as it’s more commonly referred to, is a well-known supplement for bodybuilders and others who are interested in increasing the size of their muscles. Recent research has shown that DIM could pose health hazards. For example, DIM can cause serious liver damage when consumed in excess. Another risk is kidney damage, which can lead to kidney failure. The long-term health risks of DIM have many bodybuilders and athletes ask the question: should I supplement my diet with a supplement with DIM?
The majority of people take diindolylmethane supplements to boost the production of testosterone. It is known that testosterone functions as an androgen. This means that it can cause hormonal changes within the tissues. Studies have proven DIM to mimic the effects both of testosterone and other hormones. Some manufacturers have added diindolylmethane (DIM) to their products to improve their marketability in male circles, as men produce more testosterone than women. The concept is that men respond to a product that replicates the effects of testosterone naturally produced.
Many companies promote DIM as a tumor suppressor. Although diindolylmethane can be effective in reducing tumor growth in laboratory animals, it was administered orally to the animals. To achieve the same effect in humans, diindolylmethane needs to be consumed in high doses over a prolonged period of time. The animals studied did not show indications of cancer for a number of years. However, they all developed liver disease due to consuming excessive amounts of diindolylmethane. To get a real look at the way DIM works in the body, you should contact a medical practitioner.
According to the US National Institute of Environmental Health Safety and Security, the only way to show that DIM is effective in treating breast cancer is to conduct an experiment in which cells from healthy breast cancer cells are exposed to large doses of diindolylmethane for a long period of time. Like any chemical there are pros and cons associated with using it. The advantages include the capability to mimic hormones. This means that you could create insulin, which can inhibit cancer cell proliferation. The negatives include the fact that diindolylmethane can also produce the potentially harmful chemical DMSO. Learn more about what is diindolylmethane dim now.
One of the most commonly used claims made for diindolylmethane as an option for treating various health issues is that it acts as a natural, anti-fungal, anti-bacterial, and anti-cancer agent. The National Institute of Health, through a thorough review of supportive data concluded that there was no evidence to support these claims. According to the Institute of Chemical Technology there was no evidence from any research which supported this assertion. The Institute of Chemical Safety, through an in-depth examination of the firestone’s safety profile concluded that the data presented by pharmaceutical companies about the benefits of diindolylmethane to humans was not completely reliable.
In a May 2021 edition of the Journal of Toxicology and Environmental Health, van der Goes, and others. highlighted the potential risks that could be posed by diindolylmethane’s use including allergic reactions to the skin, asthma attacks, dizziness, headaches, and respiratory issues. They also noted that the recommended daily dose for this chemical is 0.2 milligrams, which is about one tenth of one teaspoon. It is not clear what the concentration level is when compounded with other compounds. Because this substance hasn’t been thoroughly tested, it cannot be considered to be safe at any level.
The abstract of the view shows that diindolylmethane’s use in cancer treatment is based on the notion that intracellular inhibition of pyruvate metabolism by flavenoids can be inhibited and stops the accumulation of oxalates and pyruvate metabolites in the renal tubule cells. However, metabiplicate toxicity studies did not present convincing evidence that the consumption of this chemical can cause an overdose. The Food and Drug Administration approved the substance as a prescription drug in June 1996. According to the FDA the company that makes firestone Tincture is currently completing two major trials in Europe and the United States.
The abstract of the view also reveals that the use of diindolylmethane (DIEM) in the context of treating cancer is based on the principle of inhibiting intracellular inhibition of pyruvate’s pyruvate metabolite via flavenoids, and thus blocking the accumulation of oxalates in renal tubule cells as well as Adenine granulocytes. However, the drug metabiplicate toxicity studies did not provide evidence convincing that consumption of this chemical triggers an overdose. In June 1996, the Food and Drug Administration approved this drug as a prescribed drug. According to the FDA the company that makes firestone tincture is in process of completing two major studies – one in Europe and another in the United States. According to the FDA, the manufacturer of firestone tincture is in process of conducting two major trials in Europe and one in the United States.